Assessing a tumor-agnostic circulating tumor DNA assay for uveal melanoma surveillance and metastatic disease monitoring. This is an ASCO Meeting Abstract from the 2025 ASCO Annual Meeting I. This ...
Of all the types of breast cancer, triple negative breast cancer (TNBC) is the most aggressive and lacks specific therapies.
Figure illustrating how circulating tumor cells (CTCs) evade immune defenses in the bloodstream by upregulating immune checkpoints, altering MHC class I expression, forming clusters, and interacting ...
Researchers from the Institute of Industrial Science, The University of Tokyo, detail how clusters of cells detach from primary tumors and penetrate blood-vessel walls to enter the bloodstream, ...
The Nature Index 2025 Research Leaders — previously known as Annual Tables — reveal the leading institutions and countries/territories in the natural and health sciences, according to their output in ...
Impact of liquid biopsy on health-related quality of life in cancer treatment: A systematic review. This is an ASCO Meeting Abstract from the 2025 ASCO Annual Meeting I. This abstract does not include ...
Glioblastoma (GBM) is an aggressive brain tumor characterized by marked intra- and inter-tumoral heterogeneity and inevitable recurrence. Although extracranial metastasis is rare, circulating tumor ...
News-Medical.Net on MSN
DLL3 on circulating tumor cells predicts tarlatamab success in lung cancer
A team led by investigators at the Mass General Brigham Cancer Institute has discovered that a particular marker on tumor ...
Tumors are made up of millions of cells, and removing all of these cells surgically or eliminating them with medication becomes much more difficult after the cancer has spread to other parts of the ...
Spikes in circulating tumor cell clusters identified immediately preceding death. (HealthDay News) — Macrovascular infiltration and spikes in circulating tumor cell (CTC) clusters are associated with ...
SYDNEY, Dec. 10, 2025 /PRNewswire/ -- Kazia Therapeutics Limited ("Kazia" or the "Company") (NASDAQ: KZIA) today announced new data from two presentations at the 2025 San Antonio Breast Cancer ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback